1. Home
  2. ABEO vs RIV Comparison

ABEO vs RIV Comparison

Compare ABEO & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • RIV
  • Stock Information
  • Founded
  • ABEO 1974
  • RIV 2015
  • Country
  • ABEO United States
  • RIV United States
  • Employees
  • ABEO N/A
  • RIV N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • RIV Finance Companies
  • Sector
  • ABEO Health Care
  • RIV Finance
  • Exchange
  • ABEO Nasdaq
  • RIV Nasdaq
  • Market Cap
  • ABEO 256.9M
  • RIV 235.3M
  • IPO Year
  • ABEO 1980
  • RIV N/A
  • Fundamental
  • Price
  • ABEO $6.24
  • RIV $12.07
  • Analyst Decision
  • ABEO Strong Buy
  • RIV
  • Analyst Count
  • ABEO 5
  • RIV 0
  • Target Price
  • ABEO $17.80
  • RIV N/A
  • AVG Volume (30 Days)
  • ABEO 1.7M
  • RIV 87.6K
  • Earning Date
  • ABEO 05-15-2025
  • RIV 01-01-0001
  • Dividend Yield
  • ABEO N/A
  • RIV 12.85%
  • EPS Growth
  • ABEO N/A
  • RIV N/A
  • EPS
  • ABEO N/A
  • RIV N/A
  • Revenue
  • ABEO N/A
  • RIV N/A
  • Revenue This Year
  • ABEO N/A
  • RIV N/A
  • Revenue Next Year
  • ABEO $383.07
  • RIV N/A
  • P/E Ratio
  • ABEO N/A
  • RIV N/A
  • Revenue Growth
  • ABEO N/A
  • RIV N/A
  • 52 Week Low
  • ABEO $3.93
  • RIV $9.63
  • 52 Week High
  • ABEO $7.32
  • RIV $12.43
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.57
  • RIV 62.46
  • Support Level
  • ABEO $5.93
  • RIV $11.90
  • Resistance Level
  • ABEO $7.17
  • RIV $12.06
  • Average True Range (ATR)
  • ABEO 0.44
  • RIV 0.16
  • MACD
  • ABEO -0.01
  • RIV -0.01
  • Stochastic Oscillator
  • ABEO 50.00
  • RIV 57.50

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About RIV RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.

Share on Social Networks: